Skip to content
Open access

Efficacy of Inhaled Colistin versus Oral Azithromycin in Preventing Exacerbation among Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Study

Oct 2026 · International Journal of Drug Delivery Technology · Vol 16 · 0 citations · 4 references

TL;DR

Recurrent exacerbation of non-cystic fibrosis bronchiectasis should be treated with long-term antibiotics, especially those with chronic Gram-negative bacterial colonization.

Abstract

Background: Non-cystic fibrosis bronchiectasis (NCFB) is a chronic lung condition that causes ongoing inflammation of the airways of the lungs, multiple lung infections and progressive airway structural damage, resulting in repeated exacerbations and poor quality of life. Recurrent exacerbation should be treated with long-term antibiotics, especially those with chronic Gram-negative bacterial colonization. Oral azithromycin is the most commonly used treatment; it is an antimicrobial and immunomodulatory agent, while inhaled colistin

Read PDF

Similar papers

Editorial Open access Oct 2026

Evaluating the Efficacy of Brensocatib in Non-cystic Fibrosis Bronchiectasis

Bronchiectasis is a widely recognised chronic respiratory illness classified in severity by frequency of exacerbations within the past year, percent predicted forced expiratory volume in 1 second (%FEV1), previous hospital admissions and radiological severity, among other factors. The physiological process is understoo...

Alan Mathew, Hannah Anwar · 0 citations
Sep 2026

Treatment of Allergic Bronchopulmonary Aspergillosis with Dupilumab Reduces IgE Levels and is Well Tolerated in Three Children with Cystic Fibrosis.

Background:Allergic bronchopulmonary aspergillosis (ABPA) is a common complication in cystic fibrosis (CF), leading to decreased lung function and frequent pulmonary exacerbations. Standard treatments, including glucocorticoids and antifungal medications, have limited long-term benefits and are often not well tolerated...

Jeeyeon Kim, H. W. Barnes, K. Jung et al. · 0 citations
Sep 2026

Nocardia lung infection in severe asthma with immune dysfunction.

Lung infections with opportunistic pathogens, such as Pneumocystis or Nocardia, are infrequent in patients with severe asthma despite the use of high doses of inhaled or oral corticosteroids. We report two patients with severe eosinophilic asthma complicated by Nocardia infection in the respiratory tract. Both patients...

Meida Baublytė, G. Stulgytė, S. Thawanaphong et al. · 1 citation
Open access Oct 2026

Bordetella bronchiseptica isolation in chronic respiratory conditions: infection or colonization?

We report two cases of Bordetella bronchiseptica isolation from bronchoalveolar lavage fluid in patients with pre-existing lung conditions. Case 1 describes a 75-year-old male with COPD, organizing pneumonia on high-dose steroids, and presenting hemoptysis with acute pulmonary consolidations on CT, who was successfully...

E. Intini, B. Palazzotti, M. Meledandri et al. · 0 citations
Review Open access Sep 2026

Antibiotic Resistance in Recurrent Chronic Bronchitis: Challenges, Therapeutic Gaps, and the Emerging Role of Individualized Homoeopathy – A Narrative Review

In view of prolonged airway inflammation, excessive mucus production, recurring infectious exacerbations, and increasing degradation of pulmonary function, recurrent chronic bronchitis continues to be a serious therapeutic problem. Antibiotics are still essential for treating acute bacterial exacerbations, but extend...

Govind Sulkar · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.